ProKidney Corp. (PROK)
2.09
-0.10
(-4.57%)
USD |
NASDAQ |
Feb 20, 16:00
2.05
-0.04
(-1.91%)
After-Hours: 20:00
ProKidney Shareholders Equity (Quarterly) : -1.008B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 22.04M |
| Nephros, Inc. | 10.01M |
| Nautilus Biotechnology, Inc. | 169.14M |
| Neumora Therapeutics, Inc. | 132.16M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 351.61M |
| Total Liabilities (Quarterly) | 33.27M |
| Debt to Equity Ratio | -0.0042 |
| Current Ratio | 10.32 |
| Net Debt Paydown Yield | 0.15% |